-
Recent Posts
Recent Comments
Archives
- March 2018
- February 2018
- August 2017
- July 2017
- June 2017
- May 2017
- April 2017
- March 2017
- December 2016
- May 2016
- April 2016
- February 2016
- January 2016
- December 2015
- November 2015
- September 2015
- August 2015
- July 2015
- May 2015
- April 2015
- February 2015
- January 2015
- December 2014
- November 2014
- October 2014
- September 2014
- August 2014
- July 2014
- June 2014
- April 2014
- February 2014
- January 2014
- December 2013
- November 2013
- September 2013
- August 2013
- July 2013
- June 2013
- May 2013
- April 2013
- March 2013
- February 2013
- January 2013
- December 2012
- November 2012
- October 2012
- July 2012
- June 2012
- May 2012
- March 2012
- February 2012
- January 2012
- December 2011
- October 2011
Categories
- April 2012
- April 2013
- April 2016
- August 2013
- August 2014
- August 2017
- December 2011
- December 2012
- December 2013
- December 2016
- February 2012
- February 2013
- February 2014
- February 2015
- February 2016
- January 2012
- January 2013
- January 2014
- January 2016
- July 2013
- July 2014
- July/August 2012
- June 2012
- June 2013
- June 2014
- June 2017
- March 2012
- March 2013
- March 2017
- May 2012
- May 2013
- May 2016
- May 2017
- November 2011
- November 2012
- November 2013
- November 2015
- October 2012
- October 2014
- September 2014
Meta
Category Archives: January 2014
What Does a Week in San Francisco Reveal about Pharma and Biotech?
Defining what happened in San Francisco between 12 and 16 January at the J P Morgan Conference is perhaps doing a significant disservice to the Pharma and Biotech business hub of which this conference is but the core. For over … Continue reading
Posted in January 2014
Leave a comment
One Nucleus Blog 